Navigation Links
Synthetic biofilter wins through to the top 'Sweet 16' in Boston
Date:11/7/2012

This press release is available in German.

Months of painstaking work in the laboratory at Bielefeld University's Center for Biotechnology (CeBiTec) have paid off: the 15 students participating in this year's 'international Genetically Engineered Machine competition' (iGEM) at the Massachusetts Institute of Technology (MIT) have good reason to celebrate. The goal of their project was to develop a biological filter that removes estrogen from drinking water. It was a success: they managed to produce enzymes that break down the hormone. On Monday 5 November, the competition finals came to a close in Boston. From 190 teams throughout the world, Bielefeld's students made it through to the 'Sweet Sixteen', the selection of the 16 best teams in the company of teams from such prestigious universities as Stanford University (USA), the Canadian University of Calgary, and Jiaotong University in Shanghai, China.

More than 70 teams from throughout the world got through to the finals of the top student competition in synthetic biology. The Bielefeld team was one of five German teams at the start. Bielefeld University has now participated in the iGEM competition for the third year running and already succeeded in qualifying for Boston in 2010 and 2011. This year's team, like its predecessors, made it into the 'Sweet Sixteen'. 'We stand in direct comparison with universities like Stanford and Cornell. At first, that seemed very intimidating, but we soon noticed they were having to fight exactly the same problems as we were. And with our know-how, we can match the pace here', says Moritz Mller, a master student of molecular biotechnology.

Enzymes from fungi growing on trees filter out medicine residues from sewage and drinking water

Conventional methods of filtering waste water in sewage treatment plants are unable to completely remove medicine residues such as the estrogens in birth control pills. These residues then find their way into rivers and lakes and also accumulate in our drinking water. For fish and other aquatic life, estrogens can lead to reproductive and developmental disorders and even to the formation of female characteristics in males. The potential long-term consequences for human beings declining sperm counts, infertility, various cancers, and osteoporosis are still largely unknown. The Bielefeld iGEM team has developed a biological filter in which specific enzymes (so-called laccases) break down these medicine residues. One known source of particularly efficient laccases is the turkey tail, a type of fungus that grows on trees. Using methods from synthetic biology, the students succeeded in synthesizing this enzyme and applying it to filter material. 'We didn't want to invent something totally crazy with our project just because it's technically feasible. We wanted to do something that could actually be put to use in the near future, perhaps in 20 years, and be a real benefit', explains Robert Braun, a master student of molecular biotechnology. 'The biofilter is such a project. And we have shown that our idea works. In principle, a company could now come along and develop our filter further. We ourselves have got to get back to our studies most of us have rather neglected them for the last 6 months. However, the experiences we have gathered more than compensate for that'.


'/>"/>
Contact: Robert Braun
rbraun@igem-bielefeld.de
49-162-316-7424
University of Bielefeld
Source:Eurekalert  

Related biology news :

1. Collagen-seeking synthetic protein could lead doctors to tumor locations
2. Synthetic Biology Scorecard finds federal agencies responding to bioethics report
3. Synthetic diamond steps closer to next generation of high performance electrochemical applications
4. UC Santa Barbara researchers develop synthetic platelets
5. New synthetic biology technique boosts microbial production of diesel fuel
6. Could chloroplast breakthrough unlock key to controlling fruit ripening in crops?
7. Oil from algae closer to reality through studies by unique collaboration of scientists
8. An important breakthrough in the fight against muscular dystrophies
9. Humanized mice developed at OHSU enable malaria research breakthrough at Seattle BioMed
10. Tracking fish through a coral reef seascape
11. Tracking the effects of prenatal alcohol exposure through to 9 years of age
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Synthetic biofilter wins through to the top 'Sweet 16' in Boston
(Date:1/22/2016)... , January 22, 2016 ... the addition of the  "Global Behavioral ... offering. --> http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) ... "Global Behavioral Biometric Market 2016-2020"  report ... Research and Markets ( http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) has ...
(Date:1/20/2016)... Jan. 20, 2016   MedNet Solutions , an ... spectrum of clinical research, is pleased to announce the ... achievements are the result of the company,s laser focus ... eClinical , it,s comprehensive, easy-to-use and highly affordable ... --> Key MedNet growth achievements in 2015 include: ...
(Date:1/13/2016)... --> --> ... report titled - Biometric Sensors Market - Global Industry Analysis, ... to the report, the global biometric sensors market was valued at ... US$1,625.8 mn by 2023, expanding at a CAGR of ... the biometric sensors market is expected to reach 1,799.6 ...
Breaking Biology News(10 mins):
(Date:2/4/2016)... PARK, Calif. , Feb. 4, 2016   DelMar ... biopharmaceutical company focused on the development and commercialization of new ... 18 th Annual BIO CEO & Investor Conference ... in New York, NY . ... an update on the ongoing clinical trial of VAL-083 ...
(Date:2/4/2016)... 4, 2016 Sinovac Biotech Ltd. ("Sinovac" or ... of biopharmaceutical products in China , ... of directors received on February 4, 2016 a preliminary ... consortium comprised of PKU V-Ming ( Shanghai ... CICC Qianhai Development ( Shenzhen ) Fund ...
(Date:2/3/2016)... DIEGO , Feb. 3, 2016   ... company with the first pluripotent stem cell-derived islet ... diabetes in clinical-stage development, today announced that ViaCyte ... Pharmaceutical Companies of Johnson & Johnson, have agreed ... group into ViaCyte.  The agreement provides ViaCyte with ...
(Date:2/3/2016)... NEW YORK and HOLLISTON, Mass., Feb. 3, ... (Nasdaq: HART ), a biotechnology company developing ... esophagus, trachea and bronchus, today announced that CEO ... BIO CEO & Investor Conference on ... in New York City . ...
Breaking Biology Technology: